Accent Therapeutics, Inc. Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Accent Therapeutics is a biotechnology research company focused on translating the biology of RNA-modifying proteins into potential cancer therapies. It pursues this goal through a platform grounded in chemical biology and rigorous target identification and validation to advance small-molecule candidates. The company is led by an experienced team of drug developers who work to interrogate and progress small molecules with broad potential. It is headquartered in Lexington, Massachusetts. Operating in oncology, Accent Therapeutics aims to deliver precise cancer therapies. In 2026, it publicly shared preclinical data for lead compounds ATX-295 and ATX-559 at the AACR Annual Meeting, reflecting ongoing early-stage development.